Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy

Clinical Neurology and Neurosurgery
Austin K MattoxD Cory Adamson

Abstract

Gliomatosis cerebri (GC) represents an unfortunate, rare variant of glioma with a very poor prognosis. Given this lesion's rarity, little information exists on appropriate treatment options. The diffuse, infiltrative nature of GC precludes any surgical resection and limits therapy. Because of the improved survival seen with the use of temozolomide (TMZ) in malignant glioma, a rigorous systematic review of the published literature was performed to ascertain the benefit of TMZ in GC. We identified all GC cases in the literature where there was enough information to ascertain a clear response to a specific chemoradiotherapeutic treatment. In addition to our experience with a recent case, we have identified 61 patients with GC in the published literature who demonstrated a positive radiographic or clinic response after treatment. Statistical analysis of survival was performed by Kaplan-Meier analysis. A positive radiographic and clinical response was seen in patients ranging in age from 4 to 84 years. Overall median survival in patients diagnosed with GC who demonstrated a response after treatment was 25 months, with 1- and 2-year survival rates of 89% and 55%, respectively. The most common treatment regimens for responders include...Continue Reading

References

Jan 1, 1992·Neuroradiology·S A KoslowC A Jungreis
Jan 1, 1997·Brain Tumor Pathology·S KannukiK Matsumoto
Nov 12, 1998·Acta neurochirurgica·D G KimB K Cho
Feb 17, 2000·Journal of the Neurological Sciences·S ShintaniT Shiigai
Nov 28, 2001·Neurology·A BenjellounP Y Dietrich
Oct 31, 2002·Cancer·Mohamed A ElshaikhJohn H Suh
Jan 28, 2003·Cancer·Alba A BrandesMario Ermani
Aug 20, 2003·Neurosurgery·G Edward VatesMitchel S Berger
Nov 5, 2003·Medical and Pediatric Oncology·D HargraveS Baruchel
Feb 6, 2004·Brain Tumor Pathology·Hitoshi IzumiyamaNorihiko Kunii
Jul 28, 2004·Neurology·M SansonUNKNOWN ANOCEF group
Aug 26, 2004·British Journal of Neurosurgery·Y FukushimaM Tamura
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Feb 4, 2006·Magnetic Resonance Imaging·Evangelia KararizouGrhgorios Kararizos
Apr 22, 2008·Neurosurgery·Walter StummerUNKNOWN ALA-Glioma Study Group
Oct 9, 2008·Oncology·Martin GlasUlrich Herrlinger

❮ Previous
Next ❯

Citations

Jan 7, 2014·Current Treatment Options in Neurology·Roberta RudàMarc Sanson
Apr 27, 2013·Neuro-Chirurgie·J Pérez-BovetS Martín Ferrer
Mar 20, 2019·Journal of Child Neurology·Marios K GeorgakisEleni Th Petridou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
George H PerkinsMoshe H Maor
Neurología : publicación oficial de la Sociedad Española de Neurología
M E Novillo LópezJ Dalmau
Neurología : publicación oficial de la Sociedad Española de Neurología
J Bruna, R Velasco
Handbook of Clinical Neurology
Ulrich Herrlinger
© 2022 Meta ULC. All rights reserved